Skip to main content
Top
Published in: Pathology & Oncology Research 3/2008

01-09-2008 | Original Paper

K-ras Mutation, HPV Infection and Smoking or Alcohol Abuse Positively Correlate with Esophageal Squamous Carcinoma

Authors: Ioannis D. Lyronis, Stavroula Baritaki, Ioannis Bizakis, Elias Krambovitis, Demetrios A. Spandidos

Published in: Pathology & Oncology Research | Issue 3/2008

Login to get access

Abstract

The Ras/Raf/MEK/ERK (MAPK) signal transduction cascade is an important mediator of a number of cellular fates including growth, survival and apoptosis. The aim of this study was to determine the incidence of B-raf, Kirsten-ras (K-ras) and Neuroblastoma-ras (N-ras) gene mutations in esophageal squamous cell carcinoma (ESCC) in the Greek population. DNA was extracted from 30 ESCC and 32 normal esophageal specimens and screened for V600E B-raf, and K-ras/N-ras codon 12 mutations, by PCR-RFLP based analysis. Among the genes tested, only the heterozygous K-ras mutation was detected in 5 out of the 30 ESCC specimens (16%), whereas no mutation was found in the normal esophageal tissue (P < 0.022). The normal samples were screened negative for N-ras and V600E B-raf mutations. The increased risk of esophageal cancer was correlated with tobacco use (OR = 3.5, P < 0.023) and alcohol abuse (OR = 7.22, P < 0.001), accompanied with the high incidence of the k-ras codon 12 mutation (22%, OR = 1.77 and 21%, OR = 1.52), respectively. A similar positive association was seen in human papilloma virus (HPV)-infected patients (OR = 5.66, P < 0.003). Our overall findings demonstrate that the mutational activation of the K-ras gene, HPV infection and tobacco or alcohol abuse, can be considered independently or in combination as high risk factors for ESCC development.
Literature
1.
go back to reference Arber N, Shapira I, Ratan J et al (2000) Activation of c-K-ras mutations in human gastrointestinal tumors. Gastroenterology 118:1045–1050CrossRefPubMed Arber N, Shapira I, Ratan J et al (2000) Activation of c-K-ras mutations in human gastrointestinal tumors. Gastroenterology 118:1045–1050CrossRefPubMed
2.
go back to reference Arora S, Mathew R, Mathur M et al (2001) Alterations in MDM2 in esophageal squamous cell carcinoma: relationship with p53 status. Pathol Oncol Res 7:203–208CrossRefPubMed Arora S, Mathew R, Mathur M et al (2001) Alterations in MDM2 in esophageal squamous cell carcinoma: relationship with p53 status. Pathol Oncol Res 7:203–208CrossRefPubMed
3.
go back to reference Bosetti C, Gallus S, Garavello W et al (2006) Smoking cessation and the risk of oesophageal cancer: an overview of published studies. Oral Oncol 42:957–964CrossRefPubMed Bosetti C, Gallus S, Garavello W et al (2006) Smoking cessation and the risk of oesophageal cancer: an overview of published studies. Oral Oncol 42:957–964CrossRefPubMed
4.
go back to reference Fenoglio-Preiser CM (1999) Gastrointestinal pathology. An atlas and text, 2nd edn. Lippincott-Raven, Philadelphia, pp 102–103 Fenoglio-Preiser CM (1999) Gastrointestinal pathology. An atlas and text, 2nd edn. Lippincott-Raven, Philadelphia, pp 102–103
5.
go back to reference Chetty R, Simelane S (1999) p53 and cyclin A protein expression in squamous carcinoma of the oesophagus. Pathol Oncol Res 5:193–196CrossRefPubMed Chetty R, Simelane S (1999) p53 and cyclin A protein expression in squamous carcinoma of the oesophagus. Pathol Oncol Res 5:193–196CrossRefPubMed
6.
go back to reference Cohen Y, Xing M, Mambo E et al (2003) BRAF mutation in papillary thyroid carcinoma. J Natl Cancer Inst 95:625–627PubMedCrossRef Cohen Y, Xing M, Mambo E et al (2003) BRAF mutation in papillary thyroid carcinoma. J Natl Cancer Inst 95:625–627PubMedCrossRef
7.
go back to reference Davies H, Bignell GR, Cox C et al (2002) Mutations of the BRAF gene in human cancer. Nature 417:949–954CrossRefPubMed Davies H, Bignell GR, Cox C et al (2002) Mutations of the BRAF gene in human cancer. Nature 417:949–954CrossRefPubMed
8.
go back to reference Ellis A, Field JK, Field EA et al (1994) Tylosis associated with carcinoma of the oesophagus and oral leukoplakia in a large Liverpool family—a review of six generations. Eur J Cancer B Oral Oncol 30:102–112CrossRef Ellis A, Field JK, Field EA et al (1994) Tylosis associated with carcinoma of the oesophagus and oral leukoplakia in a large Liverpool family—a review of six generations. Eur J Cancer B Oral Oncol 30:102–112CrossRef
10.
go back to reference Fransen K, Klintenas M, Osterstrom A et al (2004) Mutation analysis of the BRAF, ARAF and RAF-1 genes in human colorectal adenocarcinomas. Carcinogenesis 25:527–533CrossRefPubMed Fransen K, Klintenas M, Osterstrom A et al (2004) Mutation analysis of the BRAF, ARAF and RAF-1 genes in human colorectal adenocarcinomas. Carcinogenesis 25:527–533CrossRefPubMed
11.
12.
go back to reference Kim IJ, Park JH, Kang HC et al (2003) Mutational analysis of BRAF and K-ras in gastric cancers: absence of BRAF mutations in gastric cancers. Hum Genet 114:118–120CrossRefPubMed Kim IJ, Park JH, Kang HC et al (2003) Mutational analysis of BRAF and K-ras in gastric cancers: absence of BRAF mutations in gastric cancers. Hum Genet 114:118–120CrossRefPubMed
13.
go back to reference Lam AK (2000) Molecular biology of esophageal squamous cell carcinoma. Crit Rev Oncol Hematol 33:71–90CrossRefPubMed Lam AK (2000) Molecular biology of esophageal squamous cell carcinoma. Crit Rev Oncol Hematol 33:71–90CrossRefPubMed
14.
go back to reference Lee SH, Lee JW, Soung YH et al (2003) BRAF and KRAS mutations in stomach cancer. Oncogene 22:6942–6945CrossRefPubMed Lee SH, Lee JW, Soung YH et al (2003) BRAF and KRAS mutations in stomach cancer. Oncogene 22:6942–6945CrossRefPubMed
15.
go back to reference Lord RV, O'Grady R, Sheehan C et al (2000) K-ras codon 12 mutations in Barrett’s oesophagus and adenocarcinomas of the oesophagus and oesophagogastric junction. J Gastroenterol Hepatol 15:730–736CrossRefPubMed Lord RV, O'Grady R, Sheehan C et al (2000) K-ras codon 12 mutations in Barrett’s oesophagus and adenocarcinomas of the oesophagus and oesophagogastric junction. J Gastroenterol Hepatol 15:730–736CrossRefPubMed
16.
go back to reference Lyronis ID, Baritaki S, Bizakis I et al (2005) Evaluation of the prevalence of human papillomavirus and Epstein–Barr virus in esophageal squamous cell carcinomas. Int J Biol Markers 20:5–10PubMed Lyronis ID, Baritaki S, Bizakis I et al (2005) Evaluation of the prevalence of human papillomavirus and Epstein–Barr virus in esophageal squamous cell carcinomas. Int J Biol Markers 20:5–10PubMed
17.
go back to reference Mandard AM, Hainaut P, Hollstein M (2000) Genetic steps in the development of squamous cell carcinoma of the esophagus. Mutat Res 462:335–342CrossRefPubMed Mandard AM, Hainaut P, Hollstein M (2000) Genetic steps in the development of squamous cell carcinoma of the esophagus. Mutat Res 462:335–342CrossRefPubMed
18.
go back to reference Mercer KE, Pritchard CA (2003) Raf proteins and cancer: B-Raf is identified as a mutational target. Biochim Biophys Acta 1653(1):25–40, Jun 5PubMed Mercer KE, Pritchard CA (2003) Raf proteins and cancer: B-Raf is identified as a mutational target. Biochim Biophys Acta 1653(1):25–40, Jun 5PubMed
19.
go back to reference Ramachandran S, Ramadas K, Hariharan R et al (2006) Single nucleotide polymorphisms of DNA repair genes XRC1 and XPD and its molecular mapping in Indian oral cancer. Oral Oncol 42:350–362CrossRefPubMed Ramachandran S, Ramadas K, Hariharan R et al (2006) Single nucleotide polymorphisms of DNA repair genes XRC1 and XPD and its molecular mapping in Indian oral cancer. Oral Oncol 42:350–362CrossRefPubMed
20.
go back to reference Scully C, Field JK, Tanzawa H (2000) Genetic aberrations in oral or head and neck squamous cell carcinoma 2: chromosomal aberrations. Oral Oncol 36:311–327CrossRefPubMed Scully C, Field JK, Tanzawa H (2000) Genetic aberrations in oral or head and neck squamous cell carcinoma 2: chromosomal aberrations. Oral Oncol 36:311–327CrossRefPubMed
21.
go back to reference Sommerer F, Vieth M, Markwarth A et al (2004) Mutations of BRAF and KRAS2 in the development of Barrett’s adenocarcinoma. Oncogene 23:554–558CrossRefPubMed Sommerer F, Vieth M, Markwarth A et al (2004) Mutations of BRAF and KRAS2 in the development of Barrett’s adenocarcinoma. Oncogene 23:554–558CrossRefPubMed
22.
go back to reference Spandidos DA, Sourvinos G, Tsatsanis C et al (2002) Normal ras genes: their onco-suppressor and pro-apoptotic functions (review). Int J Oncol 21:237–241PubMed Spandidos DA, Sourvinos G, Tsatsanis C et al (2002) Normal ras genes: their onco-suppressor and pro-apoptotic functions (review). Int J Oncol 21:237–241PubMed
24.
go back to reference Talamini G, Capelli P, Zamboni G et al (2000) Alcohol, smoking and papillomavirus infection as risk factors for esophageal squamous-cell papilloma and esophageal squamous-cell carcinoma in Italy. Int J Cancer 86:874–878CrossRefPubMed Talamini G, Capelli P, Zamboni G et al (2000) Alcohol, smoking and papillomavirus infection as risk factors for esophageal squamous-cell papilloma and esophageal squamous-cell carcinoma in Italy. Int J Cancer 86:874–878CrossRefPubMed
25.
go back to reference Tavani A, Bertuzzi M, Talamini R et al (2003) Coffee and tea intake and risk of oral, pharyngeal and esophageal cancer. Oral Oncol 39:695–700CrossRefPubMed Tavani A, Bertuzzi M, Talamini R et al (2003) Coffee and tea intake and risk of oral, pharyngeal and esophageal cancer. Oral Oncol 39:695–700CrossRefPubMed
26.
go back to reference Wang WKP, Schwartz M, Malon G et al (1994) PCR amplification of 40 year-old paraffin-embedded tumour tissues: comparison of four different DNA extraction and purification methods. Int J Oncol 5:0–4 Wang WKP, Schwartz M, Malon G et al (1994) PCR amplification of 40 year-old paraffin-embedded tumour tissues: comparison of four different DNA extraction and purification methods. Int J Oncol 5:0–4
27.
go back to reference Weber A, Langhanki L, Sommerer F et al (2003) Mutations of the BRAF gene in squamous cell carcinoma of the head and neck. Oncogene 22:4757–4759CrossRefPubMed Weber A, Langhanki L, Sommerer F et al (2003) Mutations of the BRAF gene in squamous cell carcinoma of the head and neck. Oncogene 22:4757–4759CrossRefPubMed
28.
go back to reference Wu M, Semba S, Oue N et al (2004) BRAF/K-ras mutation, microsatellite instability, and promoter hypermethylation of hMLH1/MGMT in human gastric carcinomas. Gastric Cancer 7:246–253CrossRefPubMed Wu M, Semba S, Oue N et al (2004) BRAF/K-ras mutation, microsatellite instability, and promoter hypermethylation of hMLH1/MGMT in human gastric carcinomas. Gastric Cancer 7:246–253CrossRefPubMed
Metadata
Title
K-ras Mutation, HPV Infection and Smoking or Alcohol Abuse Positively Correlate with Esophageal Squamous Carcinoma
Authors
Ioannis D. Lyronis
Stavroula Baritaki
Ioannis Bizakis
Elias Krambovitis
Demetrios A. Spandidos
Publication date
01-09-2008
Publisher
Springer Netherlands
Published in
Pathology & Oncology Research / Issue 3/2008
Print ISSN: 1219-4956
Electronic ISSN: 1532-2807
DOI
https://doi.org/10.1007/s12253-008-9032-1

Other articles of this Issue 3/2008

Pathology & Oncology Research 3/2008 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine